Type 1 diabetes (T1D) is a chronic autoimmune disease with a complex pathogenesis involving multiple genetic and environmental factors. Currently 15 loci have been identified that have convincing evidence for association with T1D. [1] [2] [3] [4] Interestingly, several of these T1D susceptibility loci are shared with other immune-mediated diseases, namely PTPN22, CTLA4, IL2RA, IL2, IL7R and SH2B3 (see Table 1 for full gene names). 1, 5, 6 Therefore, we sought to test newly identified rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), multiple sclerosis, ankylosing spondylitis (AS) and Crohn's disease (CD) loci for association in T1D [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] with the assumption of an increased prior probability of association based on the previous evidence of overlapping risk alleles across autoimmune diseases. 18 We selected single nucleotide polymorphisms (SNPs) for genotyping that had shown a convincing evidence of association with at least one other autoimmune disease from genome-wide association scans published over the past 2 years. We genotyped SNPs from the genes: CD58 (rs12044852) which has been associated with multiple sclerosis; 8 STAT3 (rs3816769) which has been associated with CD; 7 IL1A (rs17561) and ERAP1, previously called ARTS1 (rs30187) which have been associated with AS; 15, 17 MMEL1-TNFRSF14 (rs3890745), CDK6 (rs42041), the 7q23 gene desert (rs11761231), CCL21 (rs2812378), TRAF1/C5 (rs3761847), KIF5A(rs1678542) and CD40 (rs4810485), which have been associated with RA; 7, 12, 19 BANK1 (rs10516487), FAM167A previously called C8orf13 (rs13277113) and ITGAM (rs9888739) which have been associated with SLE [9] [10] [11] 20 and STAT4 (rs7574865) and TNFAIP3 (rs6920220 and rs10499194) which have been associated with both RA and SLE 13, 14, 16, 21, 22 (See Table 1 for full gene names).
We did not find any evidence for an association with T1D for the SNPs from the genes CD58, MMEL1-TNFRSF14, IL1A, BANK1, CDK6, FAM167A (C8orf13), CCL21, TRAF1/C5, ITGAM or CD40 (Table 2 and  Supplementary Table 1 ). The gene desert SNP on 7q23 (rs11761231) previously showed evidence for an effect in a sex-differentiated test in RA cases (P 2df ¼ 3.9 Â 10 À7 ) indicating a stronger effect in women. 7 However, we found no evidence of association with T1D (Table 2 ) or with gender (P ¼ 0.40, for the sex-differentiated test in T1D cases).
We found some evidence of an association with both STAT genes: STAT4 (rs7574865), OR for minor allele T ¼ 1.10 (95% CI ¼ 1.04-1.15), P ¼ 4.11 Â 10 À4 and STAT3 (rs3816769), OR for minor allele C ¼ 0.93 (95% CI ¼ 0.89-0.98), P ¼ 3.70 Â 10
À3
. Recently Zervou et al. 23 reported an association of STAT4 rs7574865 with T1D using 101 cases and 203 controls from Greece: OR for minor allele T ¼ 1.94 (95 CI ¼ 1.29-2.91), P ¼ 0.0012. We also found 
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evidence for an association with T1D with the two SNPs from the TNFAIP3 region (rs6920220 and rs10499194) ; respectively. The effects of the two SNPs were found to be independently associated with T1D using logistic regression analyses, as found in RA 13, 16 (Table 2 ). More recently, this gene region has also been associated with SLE in two independent studies. 21, 22 In Musone et al. 22 three independent associations conferring risk were associated with SLE, including the two SNPs previously associated with RA. However, Graham et al. 21 found two independent associations, one of which was previously associated with RA. Further analyses of the region will be required to establish if the associations in all three diseases are due to the same or different variant(s). We also found evidence for an association between T1D and KIF5A (rs1678542) OR for minor allele C ¼ 0.92 (95% CI ¼ 0.88-0.96), P ¼ 3.00 Â 10
À4
and ERAP1 (ARTS1) (rs30187) OR for minor allele T ¼ 1.07 (95% CI ¼ 1.02- Table 2 and  Supplementary Table 1 ).
Finally, we tested for an interaction with HLA using the SNPs rs7454108 and rs2187668 to tag the HLA-DRB1*04 and HLA-DRB1*03 alleles. 24 None of the genes showed any evidence for an interaction (data not shown) except for ITGAM, rs9888739 (P ¼ 3.29 Â 10 À5 for interaction test) which in a case-only analysis (7825 cases), the minor allele of which showed a protective effect in DR3/4 positive cases, OR for minor allele T ¼ 0.88 (95% CI ¼ 0.79-0.92), P ¼ 3.00 Â 10 À5 , and susceptibility in DR3/4 negative cases, OR for minor allele T ¼ 1.09 (95% CI ¼ 1.00-1.17), P ¼ 1.71 Â 10
. This observation requires further support in additional datasets before we can make any conclusions. We also tested ERAP1 (ARTS1) for an interaction with HLA class I, specifically HLA-A and HLA-B, as ERAP1 encodes a protein thought to be involved with class I antigen processing, 25 but no evidence for an interaction was observed (data not shown).
Our findings provide some evidence of an association with T1D and the candidate genes STAT3, STAT4, TNFAIP3, ERAP1 (ARTS1) and KIF5A. The effect sizes are smaller in T1D compared with the original studies in the other diseases (Table 2) , and additional studies will be required to ascertain the contribution of these genes to T1D susceptibility. Nevertheless, the results for 6q23/ TNFAIP3 surpassed a P-value threshold of 10
, which we have taken as a conservative level of significance in concluding that an association confirmed in another disease is a true effect in T1D, given that the published evidence for the association in the other disease was fully convincing and that the disorder clearly co-segregates with T1D in populations. 18 Moreover, in RA more than one variant in the TNFAIP3 region showed association with disease, indicating the presence of more than one causal variant and we observed for the T1D sample sets studied here the same effect, which would be unexpected if our T1D result was a false positive. Finally, using data from 1600 American T1D cases from the Genetics of Kidneys in Diabetes (GoKinD) study and 1704 American controls from the National Institute of Mental Health (NIMH) genotyped using the Affymetrix 500K SNP chipset, 3 we found additional support for an association with 6q23/TNFAIP3, rs6920220, OR for minor allele A ¼ 1.19 (95% CI ¼ 1.05-1.34) P ¼ 6.23 Â 10
À3
, and also with 12q13/KIF5A, rs1678542, OR for minor allele C ¼ 0.85 (95% CI ¼ 0.79-0.98) P ¼ 0.0180. The remaining 13 SNPs tested in this study, excluding CD58/rs12044852 and TNFAIP3/rs10499194 which were absent from the chip and could not be imputed, all showed P 40.05 in the USA data. Lack of association of CD58, MMEL1-TNFRSF14, IL1A, BANK1, CDK6, FAM167A (C8orf13), CCL21, TRAF1/C5 and CD40 with T1D helps to delineate pathogenic mechanisms between T1D and other autoimmune diseases, as the causal variants and their functions for these disease-associated regions are elucidated. In contrast, the TNFAIP3 region on chromosome 6q23 has now been associated with three autoimmune diseases, and we can now conclude that it (assuming it is the TNFAIP3 gene itself that is causal) may well have a key role in the immune system and general regulator of immunity and autoimmunity, a speculation that is consistent with its known role in modulating cellular functions, including cell activation, cytokine signalling and apoptosis through its action as a negative regulator of the pleiotropic NF-kB pathway. 26 
